We have previously shown MTHFD2 and enzymes of the one-carbon folate pathway to be highly expressed in AML, with inhibition of MTHFD2 leading to a decrease in AML viability in vitro and in vivo [13]. The gene discussed is MTHFD2; the disease is acute myeloid leukemia.